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A B S T R A C T   
Objective: To compare nodule enhancement on subtraction CT iodine maps to that on dual-energy CT iodine maps 
using CT datasets acquired simultaneously. 
Methods: A previously-acquired set of lung subtraction and dual-energy CT maps consisting of thirty patients with 
95 solid pulmonary nodules (≥4 mm diameter) was used. Nodules were annotated and segmented on CT angi-
ography, and mean nodule enhancement in the iodine maps calculated. Three radiologists scored nodule visi-
bility with both techniques on a 4-point scale. 
Results: Mean nodule enhancement was higher (p < 0.001) at subtraction CT (34.9 ± 12.9 HU) than at dual- 
energy CT (25.4 ± 21.0 HU). Nodule enhancement at subtraction CT was judged more often to be “highly 
visible” for each observers (p < 0.001) with an area under the curve of 0.81. 
Conclusions: Subtraction CT is able to depict iodine enhancement in pulmonary nodules better than dual-energy 
CT.   
1. Background 
Lung cancer is the leading cause of cancer death among men and 
women worldwide [1]. Early characterization of incidental nodules 
could be an opportunity to reduce negative biopsies and start treatment 
earlier and increase survival [2–4]. CT imaging can characterize nodules 
based on morphology, volume and growth [5]. Since these character-
istics do not always allow for a differentiation between benign and 
malignant nodules, other features are being explored. Studies have 
suggested that nodule enhancement after contrast injection differs be-
tween benign and malignant nodules, although overlap exists [6–8]. 
Several studies have shown the feasibility or potential of character-
ization of nodules with dual-energy CT acquisition [9–11]. Subtraction 
CT as an alternative technique to depict nodule enhancement has not 
been studied yet. Subtraction CT is a recently introduced technique that 
generates iodine maps of the lungs by subtracting a pre-contrast CT from 
a contrast-enhanced CT after motion correction [12]. Even with 
differences in inspiration between the two scans, the iodine enhance-
ment maps with this technique have been shown to be accurate for 
detection of perfusion defects in the pulmonary parenchyma, with 
similar diagnostic performance as dual-energy CT [13,14]. However, 
perfusion defects are relatively large, usually in the centimeter range, 
while pulmonary nodules of clinical interest are as small as 4 mm [3]. 
Since the contrast-to-noise and signal-to-noise ratio of subtraction CT 
has been shown to be better than that of dual-energy CT [15,16], we 
hypothesize that subtraction CT might be superior to dual-energy CT to 
depict nodule enhancement. 
The goal of our study was therefore to quantitatively and qualita-
tively compare nodule enhancement on subtraction CT iodine maps to 
that on dual-energy CT iodine maps using simultaneously acquired CT 
datasets. 
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2. Methods and materials 
2.1. Study population 
For this retrospective analysis, data from a prospective study that 
recruited 295 patients between July 2016 and April 2017 with ethical 
board approval (NL56542.091.16, clinicaltrials.gov number: 
NCT02890706) in the Meander Medical Centre was used [14]. Patients 
that fulfilled the inclusion criteria were patients referred to dual-energy 
CT due to suspicion for pulmonary embolism following the Wells 
criteria. At the imaging site, women below 35 years of age are not 
referred to dual-energy CT due to concerns about breast irradiation. 
Therefore, exclusion criteria included males below 35 years old, in 
addition to patients with hemodynamic instability. 
2.2. Generation of images 
All included patients underwent the dual-energy CT angiography 
(Definition Flash, Forchheim, Germany) for pulmonary embolism pro-
tocol, with the following settings: 100 kV and 140 kV + Sn filter, refer-
ence tube current: 89 mAs and 76 mAs, respectively, rotation time: 
0.28 s, and pitch: 0.55. Prior to the contrast-enhanced scan, the partic-
ipants received a pre-contrast CT scan at 100 kV (reference tube current: 
66 mAs), for research purposes only. Breathing instructions were iden-
tical for the pre-contrast and the contrast-enhanced CT scan. 
The intravenous contrast injection (5 mL/s) consisted of 60 mL of 
350 mg I/mL (Xenetix, Guerbet Group, Paris, France) agent with 40 mL 
of saline chaser. After contrast-injection, the delay time was 5 s after a 
relative threshold of 60 Hounsfield Unit (HU) was reached in a region of 
interest in the pulmonary trunk. 
All scans were reconstructed to 1 mm thin slices with an increment of 
0.6 mm, with the Q30f filter. Dual-energy virtual iodine maps, which 
show the iodine enhancement in tissue, were generated with Syngo.Via 
(Version 3, Siemens Healthineers, Forchheim, Germany). These maps 
show the whole body cross-section. Iodine maps from subtraction CT 
were generated by subtracting the pre-contrast 100 kV scan from the 
contrast-enhanced 100 kV scan using dedicated subtraction software 
that geometrically registered the pre-contrast scan to the contrast- 
enhanced scan (sureSubtraction Lung Version8, Canon Medical Sys-
tems, Otawara, Japan). These maps show only the segmented lung 
parenchyma. 
2.3. Lung nodule dataset 
All participants with at least one solid lung mass were identified by 
one radiologist with nine years of experience in thoracic radiology based 
on the radiological report and the CT angiography data during the 
prospective study. For this retrospective study, the same radiologist 
reviewed all those cases, using a dedicated lung screening workstation 
(Veolity version 1.5, Mevis Medical Solutions AG, Bremen, Germany), 
and selected patients with nodules with a diameter between 4− 30 mm 
surrounded by pulmonary parenchyma. Consolidations, ground glass 
nodules, lesions with cavities, calcifications or hilar lesions and previ-
ously irradiated lesion were excluded. In patients with multiple nodules, 
a maximum of 15 nodules were randomly selected. 
2.4. Quantitative study 
To quantify enhancement in iodine maps from subtraction CT and 
dual-energy CT, the nodule segmentation obtained on the contrast- 
enhanced CT scan was transferred directly to the respective iodine 
maps, and average enhancement of the nodule was automatically 
calculated from these maps. Transfer of the segmentation of CT angi-
ography to the iodine maps was possible because of identical geometry: 
the low and high-kV data of the dual-energy share the same geometry 
and only the pre-contrast scan was registered to the contrast-enhanced 
CT angiography for subtraction CT. Mean nodules enhancement was 
measured on grey scale iodine maps in Hounsfield Units (HU), both for 
subtraction CT and dual-energy CT. 
2.5. Observer study 
Per patient, the two smallest nodules were selected for the observer 
study. Three radiologists (one with experience with subtraction CT and 
nine years’ experience in thoracic radiology, one with experience with 
dual-energy CT and more than 20 years’ experience in thoracic radi-
ology, and one no experience with either subtraction or dual-energy CT 
and more than 20 years’ experience in thoracic radiology) scored the 
visibility of nodule enhancement on a dedicated in-house scoring 
workstation. An iodine map from either subtraction or dual-energy CT 
and the 100 kV CT angiography were displayed side-by-side. Observers 
were able to interactively adapt window with, window level, viewing 
direction (axial, coronal, sagittal), slice thickness, and viewing mode 
(average or maximum intensity projection) to simulate a clinical setting. 
A list of the two nodules was displayed on the workstation next to the CT 
angiography and the corresponding iodine map. To review each nodule, 
the observer clicked on each nodule on the list, upon which the correct 
slice was shown in both images. In addition, a marker was placed on the 
correct region of the image on the CT angiography. This ensured that the 
same nodule was being evaluated on both images. Since iodine maps 
from subtraction images were only displaying the lung fields, while 
dual-energy iodine maps displayed the whole scan field, the two datasets 
were easily distinguishable and therefore scored separately in random 
order. 
Observers were instructed to score the visibility of each nodule on 
the iodine maps on a four-point scale (1: clearly visible, 2: partially 
visible, 3: hardly visible, 4: invisible). In order to evaluate the potential 
impact of the difference in diaphragm level between the pre-contrast 
and contrast-enhanced CT on the visibility of the nodule enhancement 
in subtraction CT, a subset of all scans with a diaphragm level difference 
larger than 6.0 mm was selected. This threshold was used since this had 
been found to be the average difference in the clinical setting [13]. 
2.6. Statistical analysis 
A paired t-test was used to determine significance of differences in 
mean nodule enhancement on iodine maps obtained with dual-energy or 
subtraction CT. A Wilcoxon-signed-rank test was used per observer to 
determine any significant difference in visibility scores between sub-
traction CT and dual-energy CT iodine maps. Furthermore, we used vi-
sual grading characteristics (VGC) analysis to determine the difference 
in visibility scores between the two techniques, which was summarized 
using the area under the VGC curve of the mean observer [17–20]. To 
determine if a diaphragm difference > 6 mm between the pre-contrast 
and contrast-enhanced CT scans had a negative influence on the 
enhancement of the nodule in the subtraction CT iodine map, a 
Kruskal-Wallis test was performed, by comparing the visibility scores of 
the images with large diaphragm difference (> 6 mm) to the ones with a 
small difference (≤ 6 mm). A paired t-test was used to determine if there 
was a significant difference in radiation dose across techniques. 
3. Results 
In total, 42 patients were identified to have solid masses or nodules. 
Eight patients were excluded since the nodules were hilar, were not 
surrounded by pulmonary parenchyma (4), or were ground glass lesions 
or consolidations (4). Four had previous radiotherapy. Therefore, the 
final dataset consisted of 30 patients (16 male, 14 female; age: mean 
67.1 +/- 9.9 years, range 47–80 years) with 95 nodules that fulfilled the 
criteria. The median dose length product was slightly, but significantly, 
lower with subtraction CT (154.6 mGy cm than with dual-energy CT 
(161.8 mGy cm p < 0.001). 
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3.1. Quantitative enhancement 
The median nodule volume was 237.1 mm3 (equivalent to a diameter 
of 8 mm). Mean nodule enhancement on iodine maps from subtraction 
CT was 34.9 HU (SD: ± 12.9 HU) compared to a mean enhancement of 
25.4 HU (SD: ± 21.0 HU) on the dual-energy CT iodine maps. This 
difference was significant at p < 0.001. 
3.2. Observer study 
The observers scored 43 nodules (median volume: 223.3 mm3, 
equivalent diameter of 8 mm) from 30 patients. Fig. 1 shows histograms 
of each observer ratings for visibility per nodule. It shows that nodules in 
subtraction CT were judged to be visible significantly more often 
compared to with dual-energy CT for each observer (p < 0.001). Fig. 2 
shows the VGC curve, resulting in an area under the curve of 0.81, with 
preference for the visibility of nodule enhancement in subtraction CT 
compared to dual-energy CT. Figs. 3–5 show examples of nodule 
enhancement with subtraction CT and dual-energy CT. 
The average diaphragm level difference between the pre-contrast 
and the contrast-enhanced CTs for all 30 patients was 5.1 mm. Seven 
patients with nine nodules had a larger diaphragm level difference than 
the average 6.0 mm. The subtraction CT median score for visibility for 
all observers in these nodules (median volume: 440.6 mm3, equivalent 
diameter of 9 mm) was also 1.0 and the statistical test showed a non- 
significant difference between the visibility scores (p = 0.97). There-
fore, the large diaphragm differences did not affect nodule enhancement 
visibility. 
Fig. 1. Histograms of visibility scores from each observer and for all observers combined for all 43 nodules evaluated, with the resulting p-values from comparing the 
distributions using the Wilcoxon-signed-rank test. SCT = subtraction CT iodine maps, DECT = dual-energy CT iodine maps. 
Fig. 2. The VCG curve of a plot of the proportion of ratings above a certain 
threshold for the subtraction CT against the same proportion for dual-energy CT 
at various threshold settings. The Figure shows the separation between sub-
traction and dual-energy CT (green line). The area under the curve of 0.81 
shows a higher visibility in preference of subtraction CT. The blue line is the 
reference line were both technique shows the same preference (line y = x). 
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4. Discussion 
This study shows that subtraction CT can depict nodule enhancement 
better than dual-energy CT, and that this depiction is not affected by the 
difference in diaphragm level between the pre-contrast and contrast- 
enhanced CT scan, making the technique robust. 
No other studies have been performed on characterizing the differ-
ence in pulmonary nodule depiction in patient iodine maps between 
subtraction and dual-energy CT. A phantom-based observer study has 
shown similar results due to the better depiction of iodine enhancement 
in plastic tubes in an abdominal phantom in subtraction CT compared to 
dual-energy CT [15]. 
Since 1997, researchers have investigated the enhancement in CT 
angiography scans of pulmonary nodules, as a feature for nodule char-
acterization [21]. In that study by Zhang et al, the clear difference in 
enhancement between malignant and benign studies was shown. In the 
studies of Swenson et al. and Yi et al, high sensitivity values were shown, 
both above 98 % with a threshold of 15 HU and 30 HU, respectively. 
However, both studies also showed a low specificity (58 % and 54 %, 
respectively), due to benign nodules also resulting in high enhancement 
[6,22]. Later, multiple studies tried to improve nodule characterization 
by investigating the contrast wash-in and wash-out rates [7,8,22]. These 
showed that with the inclusion of this additional information, the 
specificity could reach 79 % or higher. In 2014, Ohno et al., with a large 
prospective study, showed that they were able to characterize pulmo-
nary nodules with dynamic CT angiography. However, it should be 
noted that, for this, they did not distinguish only between malignant and 
benign nodules, but added a third category: benign with high biologic 
activity [23]. This latter group was probably the main reason why there 
had been overlap between benign and malignant lesions in earlier 
studies. 
This study evaluated the feasibility of visualisation of contrast 
enhancement by subtraction and dual energy CT. This might help in 
better characterisation of nodules, but this could not properly be 
investigated in this study. This is because the CT scans in this study were 
acquired with early contrast timing, which is not optimal for nodule 
Fig. 3. (left) CT angiography shown with a lung window (window level/width = -500/1500), with a 5.6 mm nodule in the left upper lobe (arrow). (middle) The 
subtraction iodine map shows clear enhancement of the nodule according to all observers, and (right) the dual-energy CT iodine map shows enhancement that was 
scored as partially visible by one observer, and as hardly visible by two observers. 
Fig. 4. (left) CT angiography shown with a lung window (window level/width = -500/1500), with a 6.6 mm nodule in the left lower lobe (arrow). (middle) The 
subtraction iodine map shows clear enhancement of the nodule according to two observers, but not visible according to the third observer, and (right) the dual- 
energy CT iodine map shows enhancement that was scored as clear by all observers. 
Fig. 5. (left) CT angiography shown with a lung window (window level/width = -500/1500), with an 18.2 mm nodule in the right lower lobe (arrow). (middle) The 
subtraction iodine map shows clear enhancement of the nodule according to all observers, and (right) the dual-energy CT iodine map showing the nodule with a 
visibility assessed as clear by one observer, hardly visible by one observer and not visible by the third observer. 
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characterisation. The previously described literature on nodule charac-
terisation used later phases or four-dimensional scanning to discrimi-
nate between benign and malignant nodules. However, given the better 
enhancement depiction in subtraction CT, and given the previous 
characterization results with dual-energy CT, it is likely that with the 
correct scan timing, subtraction CT could be of added value when 
attempting to distinguish among benign, malignant, and biologically- 
active benign nodules. The additional dose that is needed for the pre- 
contrast CT included in subtraction CT is relatively low compared to 
that used during full treatment (radiotherapy or additional CTs), while 
the additional information could be useful for achieving earlier diag-
nosis. The impact of subtraction CT on any possible earlier diagnosis 
remains to be investigated, but a clinically-significant reduction in time 
to diagnosis could improve patient outcome. 
The last limitation was that the masking of the lung parenchyma on 
subtraction CT posed a potential bias against subtraction because seven 
peripheral nodules were partially or fully excluded from the iodine map, 
which caused the observers to downgrade their visibility. Better lung 
masking should therefore shift the results even more in favor of sub-
traction CT. 
In conclusion, subtraction CT is a novel technique that is able to 
depict the iodine enhancement in pulmonary nodules better than dual- 
energy CT, no matter the difference in respiratory levels between the 
pre-contrast CT and contrast-enhanced CT. 
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